Site icon Healthcare, Lifestyle, Entertainment, Living and Travel

FDA sets target action date for Rhythm’s sNDA for Imcivree (NASDAQ:RYTM)


To guarantee this doesn’t occur sooner or later, please allow Javascript and cookies in your browser.

Is this occurring to you often? Please report it on our suggestions discussion board.

If you’ve an ad-blocker enabled chances are you’ll be blocked from continuing. Please disable your ad-blocker and refresh.



Source: Seekingalpha

Exit mobile version